Gardasil Fails to Protect Against Cervical Intraepithelial Neoplasia Over Time

The US Food and Drug Administration (FDA) approved the first human papilloma virus (HPV) vaccine in 2006 progressing to Gardasil 9, a 9-valent vaccine, for use in children as young as 9 years old in December 2014. The CDC recommends the HPV vaccine as part of the routine vaccination schedule for children ages 11–12, but it can be given as early as age 9. The vaccine is also recommended for adults up to age 26, and in 2018 the FDA expanded the age range to include adults up to age 45.

Adcock et al obtained data from January 1, 2007, to December 31, 2020, from the New Mexico HPV Pap Registry (NMHPVPR), the only comprehensive US statewide monitoring system for cervical cancer prevention. Over fourteen years through which the HPV vaccination should have had a population effect, the results are disappointing for the higher grades of cervical intraepithelial neoplasia 2 and 3, which are findings from a cervical biopsy that indicates abnormal cells on the cervix’s surface. It’s also known as high-grade or moderate dysplasia (CIN-2) and carcinoma in situ (CIN-3). CIN 2/3 is usually caused by infection with certain types of human papillomavirus (HPV).

Keep reading

Clinical Trials of Childhood Vaccines: No Placebo-Controlled Long-Term Trials

Not a single routine childhood vaccine was licensed based on a long-term placebo-controlled trial. Not one. See the carefully created and fully referenced chart at https://icandecide.org/no-placebo which was compiled by our firm with funding from the Informed Consent Action Network (ICAN).

I will also be holding a Spaces event on Twitter this Tuesday at noon Eastern time to discuss this chart: https://twitter.com/i/spaces/1ynJODQVbDXxR. See you there!

Keep reading

The mainstream media is helping Big Pharma promote high-profit weight loss injections

The mainstream media has long been used to advertise for and support the pharmaceutical industry, and anyone who has ever doubted this is the case was proven wrong by the way the media handled COVID-19 vaccines. Now, the “solution” they’re pushing on the masses is the weight loss drug Ozempic and others of its ilk, and much like the vaccines, they’re doing their best to gloss over the dangerous side effects.

Multiple mainstream media outlets have been doing segments on Ozempic, not only touting the injectable diabetes drug’s weight loss benefits but also pointing to other supposed benefits, like a clip on NBC that claimed it can reduce the risk of cancer.

What they’re not talking about nearly as much are the scary side effects of these so-called weight loss “miracles,” but that shouldn’t be surprising when you consider how heavily pharmaceutical companies advertise in the mainstream media. No one working for these outlets would want to write anything that risks upsetting the companies helping pay their salary.

Dr. Guy Hatchard, a natural medicine advocate with a Ph.D. in Psychology, recently called out the corporate media for this practice, focusing on a lead article in The New Zealand Herald entitled “Wellington company director Finlay Thompson loses 30kg taking Ozempic, wants medication funded.”

Written by a young journalist, Ethan Manera, it discusses how the company director in question shed 66 pounds while participating in a U.S.-based trial of the drug and receiving it for free. As the trial period comes to a close, he is asking the government to fund the drug for himself and others who need to lose weight. In Thompson’s case, he simply can’t control his eating and has failed at multiple other attempts to lose weight.

Keep reading

The Cult Of Vaccination

Vaccines are a pharmaceutical product. Yet they are treated like mana from God. To question a vaccine is blasphemy. There is so much faith in vaccines that pregnant women are now offered the flu, Tdap, COVID, and RSV, vaccines as a routine part of their prenatal care. Curiously the CDC started to call pregnant women, pregnant people and boldly claim that vaccines are safe for “pregnant people”. 

Every vaccine has this in section 8.1 of the manufacturer’s insert. Most pregnant women do not know about the pregnancy registry. What do we actually know about vaccines in pregnancy? Studies of pregnant woman given vaccines are done by the manufacturer, and those studies are heavily biased and insufficient. You can find all the vaccines on the market today on the FDA website. Also see testimony in New Hampshire by Attorney Aaron Siri about vaccine safety. Aaron Siri is a managing partner with Siri and Glimstad, they specialize in vaccine safety and injury. All licensed vaccines list their clinical trials. Aaron Siri goes into great detail on this. The vaccines on the market today lack proper safety clinical trials with true inert placebos. The Hepatitis B vaccine given to all newborn babies was studied for FIVE DAYS! See that for yourself HERE

Keep reading

‘Fraud, Pure and Simple’: Merck Mumps Vaccine May Contain Up to 4 Times Approved Amount of Live Virus

Drug manufacturer Merck misrepresented the efficacy of its mumps vaccine for years, “overfilling” the vaccine with live mumps virus to meet efficacy targets despite the lack of safety testing — and the practice may be continuing today.

Merck appears to have concealed the practice from public health agencies, which have taken no action to stop it.

Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense, joined “The Defender In-Depth” this week to discuss the revelations, which stem from a lawsuit two Merck whistleblowers filed in 2010 under the False Claims Act.

The 3rd Circuit U.S. Court of Appeals in Philadelphia heard oral arguments in the case on July 9.

According to Hooker, the Merck measles, mumps rubella vaccine, MMR II — the only mumps vaccine licensed in the U.S. and listed on the childhood vaccine schedule for 12- to 18-month-olds — may contain up to 4 times the approved concentration of live mumps virus.

two-part deposition by Dr. David Kessler, former head of the U.S. Food and Drug Administration (FDA), also indicates that Merck, rather than informing regulators that it was “overfilling” its MMR vaccine, relied on passive surveillance — reports from parents regarding vaccine reactions in their children — to identify possible safety signals.

Keep reading

U.S. Government ‘Saddled’ With COVID Vaccine Injury ‘Mess’ — While Vaccine Makers Avoid Liability

As early as January 2022, National Institutes of Health (NIH) researchers were aware of at least 850 peer-reviewed case reports and/or research articles about COVID-19 vaccine reactions, according to emails obtained by Children’s Health Defense (CHD).

In one email (name and agency redacted), NIH researchers were told the federal government was “saddled” with the “mess” of dealing with those injured by the COVID-19 vaccines, due to the liability shield enjoyed by vaccine manufacturers.

The emails, part of a 309-page batch of documents released to CHD on June 21, originated from a U.S. Food and Drug Administration (FDA) request to NIH researchers for input on a report highlighting several injuries common among people who received the vaccines.

CHD requested the documents via a Freedom of Information Act (FOIA) request to the NIH in November 2022. When the NIH hadn’t responded by April 2023, CHD sued the agency.

In an October 2023 settlement, the NIH agreed to produce up to 7,500 pages of documents at a rate of 300 pages per month.

The batch of documents released in June — which include emails to Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research — revealed that by fall 2021, key NIH researchers were aware of scientific studies on serious adverse events, including persistent neurological symptoms, following COVID-19 vaccines.

As with prior releases of the NIH documents, June’s tranche also included several emails from vaccine-injured individuals to NIH researchers, seeking help for their symptoms — with one person asking, “Why aren’t you studying vaccine injuries?”

Keep reading

Longtime pro-jab apologist finally comes clean about lack of science proving vaccine safety

After decades of aggressively promoting vaccines of all kinds, Dr. Stanley Plotkin, the world’s leading vaccinologist, is finally coming clean about the fact that vaccine safety has never been robustly studied as he has long claimed.

A paper he co-authored that was published in The New England Journal of Medicine (NEJM) on July 6, 2024, reveals that no vaccine has ever been properly studied either before or after their release.

Aaron Siri tweeted a lengthy post about Plotkin’s new paper in the NEJM, which admits that “prelicensure clinical trials have limited sample sizes [and] follow-up durations,” as well as that “there are not resources earmarked for postauthorization safety studies.”

“That is an incredible reversal,” Siri said before unpacking the rest of the study’s damning revelations basically indicting the vaccine industry and Big Pharma for science fraud.

“For decades, the medical community insisted vaccines are the most thoroughly studied product ever; for example, Dr. Paul Offit said, ‘I think we should be proud of vaccines as arguably the safest, best tested things we put in our body,'” Siri further explained.

“For decades, parents of vaccine injured children, vaccine injured adults, and other stakeholders contested these claims only to be shunned and attacked by the medical community and health agencies.”

(Related: At the 2020 Advisory Committee on Immunization Practices [ACIP] meeting, Plotkin, often referred to as ‘the godfather of vaccines,’ promoted Donald Trump’s COVID injections before they were even released under Operation Warp Speed.)

Keep reading

‘Highly Confidential’: Former FDA Chief Details Fraud in Merck’s Testing, Marketing of Mumps Vaccine

For decades, Merck misrepresented the efficacy of its mumps vaccine, marketing an “adulterated” drug without proven efficacy to millions of American children, according to a recently released expert report by Dr. David Kessler, former head of the U.S. Food and Drug Administration (FDA).

The report — posted in two documents and marked “highly confidential,” for “attorneys’ eyes only” — provides over 800 pages of Kessler’s opinion and analysis about the history and severity of Merck’s regulatory violations over decades, beginning in the late 1990s.

By 1998, regulatory labeling review had revealed that the mumps component of Merck’s measles, mumps rubella vaccine, MMRII, did not maintain the stated potency over its shelf-life, in violation of FDA regulations.

Rather than recalling the vaccine or attempting to develop a different formula, the company spent years trying to develop new and more sensitive ways to test the existing vaccine that would show high efficacy results, so it would still be in compliance with regulatory requirements and allow Merck to maintain its exclusive license.

Merck did this even though its existing data showed the vaccine was significantly less effective than claimed, Kessler wrote.

To temporarily make the drug meet Merck’s efficacy claims while the company developed tests, Merck increased the dosage of virus present in the vaccine — with the FDA’s knowledge — although the higher dosage was never tested in clinical trials for either safety or efficacy.

The company did not inform the vaccine recipients, providers or purchasers — including the Centers for Disease Control and Prevention (CDC), which purchased the drug through its Vaccines for Children Program — that its vaccine was out of compliance.

Merck’s actions, Kessler wrote, had important “public health significance.”

According to the report, starting in 2006 and recurring since then, there has been a resurgence of mumps outbreaks in the U.S. The largest outbreak in 2017 affected more than 10,000 people in 46 states.

The vast majority of the people infected in all of the outbreaks received the recommended two-dose regime of Merck’s MMR vaccine, the report says.

Keep reading

Pfizer is acquiring drug companies to profit from chronic diseases caused by their own COVID-19 “vaccines”

If you want to know the long-term side effects of the COVID-19 vaccines, pay close attention to Pfizer’s latest acquisitions. Since the rollout of their COVID-19 vaccine, Pfizer has acquired specific pharmaceutical companies that treat immune-inflammatory diseases, heart inflammation and various cancers. As their experimental use vaccine was being mandated on the population (including on the military) Pfizer was investing in drugs that target health conditions that were created and/or exacerbated by their experimental vaccines.

Pfizer acquired a drug company that treats immune-inflammatory diseases, including myocarditis

For instance, in 2021, Pfizer acquired Arena Pharmaceuticals. The price tag of the acquisition was disproportionate to the market size of the drug they acquired, but the shrewd Pfizer executive team knew the acquisition would be worth it in the end. By acquiring Arena Pharmaceuticals, Pfizer was able to control the future of therapeutics for various immune-inflammatory diseases, including drugs that address heart inflammation (myocarditis and pericarditis). These health problems skyrocketed after 2021, when Pfizer’s COVID-19 vaccines were unlawfully mandated on populations and haphazardly placed on the CDC’s childhood vaccine schedule. Today, Pfizer is profiting from health issues that they caused, keeping people in a state of illness and pharmaceutical dependence.

Pfizer acquires drug company that treats various cancers, capitalizing on the turbo cancer epidemic

By 2023, Pfizer spent $43 billion of their vaccine profits to acquire Seagen Pharmaceuticals, a little-known drug company that specializes in cancer treatments. Now, Pfizer is profiting from the surge in turbo cancers that are affecting vaccinated people of all age groups. Turbo cancer is a new phenomenon where oncologists describe a new wave of aggressive cancers that that kill people in weeks or days, as opposed to months or years. There’s no doubt that something is causing immunodeficiency. The very thing that populations were told to take to protect those with immunodeficiency has created an entire new class of people with immunodeficiency and turbo cancers. Meanwhile, their destructive biological weapons remain on the market, ensuring that these health issues continue to be profitable ventures for years to come.

Keep reading

RSV Vaccine Now Killing Babies — VAERS Reports

At least two infants died after they were mistakingly given Pfizer’s respiratory syncytial virus (RSV) vaccine along with Nirsevimab, a monoclonal antibody injection approved for infants that’s meant to prevent RSV.

A 29-day-old premature girl died after receiving an RSV shot meant for the elderly, according to the Vaccine Adverse Event Reporting System (VAERS).

“According to the mother, the patient departed the clinic at 1 pm after the vaccine was administered. Subsequently, the patient took a nap and at approximately 8 pm, the father observed that the patient was not breathing. The parents attempted CPR but it was unsuccessful,” the VAERS report said. “Shortly thereafter, the parents called both ambulance and police assistance. Upon the paramedics” arrival, the patient had already deceased; The causes of death are unknown, An autopsy is presently in the process of being investigated. The mother has not yet reported the exact cause of death, information was given via a telephone call.”

A 27-day-old boy also received the RSV shot, which resulted in a similar fate.

“Her son was only 27 days old and received the vaccine at doctor”s office and he passed away right there; Her son was only 27 days old and received the vaccine at doctor”s office and he passed away right there; This is a spontaneous report received from a Consumer or other non HCP. A 27-day-old male patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient”s relevant medical history and concomitant medications were not reported,” the VARES report said. “The following information was reported: DEATH (death, medically significant), outcome “fatal”, PRODUCT USE ISSUE (non-serious), outcome “unknown” and all described as “Her son was only 27 days old and received the vaccine at doctor”s office and he passed away right there”. The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. The information on the batch/lot number for rsv vaccine prot.subunit pref 2v, rsv vaccine prot.subunit pref 2v will be requested and submitted if and when received.; Reported Cause(s) of Death: Her son was only 27 days old and received the vaccine at doctor”s office and he passed away right there.”

Keep reading